1. Japan Stocks

  2. •

    Commercial services

  3. •

    Miscellaneous commercial services
WDB coco Co., Ltd.

WDB coco Co., Ltd.

TTSE:7079
2,544.00
JPY
-14.00
(-0.55%)
6.24BMarket Cap
Nov 06Next Earn
WDB coco Co., Ltd.
TSE:7079
(Tokyo Stock Exchange)

Recent

price

2,544.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
641.95
890.85
1,100.39
1,123.6
1,529.07
1,703.73
1,912.06
2,215.02
2,002.53
- -
Revenue per Share
86.75
118.33
147.59
163.11
273.94
311.24
356.9
379.61
282.47
- -
Basic EPS, GAAP
66.19
133
161.18
127.58
298.65
189.29
284.98
452.65
216.75
- -
Free Cash Flow per Basic Share
35.01
51
61.14
33.91
34.96
39.98
41.01
75.02
80
- -
Dividend per Share
228.43
287.36
541.51
664.82
899.39
1,166.91
1,481.82
1,786.4
1,988.87
- -
Book Value per Share
228.43
287.36
541.51
664.82
893.72
1,154.15
1,382.39
1,698.72
1,915.26
- -
Tangible Book Value per Share
2
2
2
2
2
2
2
2
2
2
Basic Weighted Avg Shares
1,467
1,782
2,286
2,571
3,615
4,071
4,596
5,327
4,816
- -
Sales/Revenue/Turnover
20.26
18.98
20.72
20.41
26.65
26.67
27.7
24.52
19.88
- -
Operating Margin (%)
1
3
9
11
18
32
33
56
57
- -
Depreciation Expense
198
237
307
373
648
744
858
913
679
- -
Net Income, GAAP
33.24
30.02
31.22
29.22
32.55
31.64
32.61
30.29
29.57
- -
Effective Tax Rate (%)
13.51
13.28
13.41
14.52
17.92
18.27
18.67
17.14
14.11
- -
Profit Margin (%)
490
633
1,104
1,449
1,903
2,329
3,132
3,815
4,331
- -
Working Capital
- -
2
5
14
22
13
14
17
55
- -
LT Debt
522
657
1,237
1,571
2,148
2,803
3,564
4,296
4,783
- -
Total Equity
- -
33.61
29.57
23.18
29.79
25.96
24.24
21
13.97
- -
Return on Invested Capital (%)
- -
40.05
32.19
26.32
34.34
29.7
26.74
23.07
14.79
- -
Return on Capital (%)
- -
40.16
32.37
26.58
34.83
30.04
26.95
23.23
14.96
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
- -
25
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
55
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
6,459
6,241
6,168

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
4,653
4,967
- -
Cash, Cash Equivalents & STI
3,502
3,762
- -
Accounts Receivable, Net
1,098
1,159
- -
Inventories
4
2
- -
Total Current Liabilities
708
636
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
25
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
25.25%
11.33%
Free Cash Flow
- -
32.84%
-52.12%
Net Income, GAAP
- -
16.91%
-25.59%
Sales/Revenue/Turnover
- -
14.49%
-9.59%
Total Cash Common Dividend
- -
22.99%
6.64%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
5,327
2026
- -
- -
- -
- -
4,816
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
379.61
2026
- -
- -
- -
- -
282.47
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
75.02
2026
- -
- -
- -
- -
80
2027
- -
- -
- -
- -
- -
Similar Companies
PayPal Holdings, Inc. (NASDAQ:PYPL)
Shopify Inc. (NASDAQ:SHOP)
Greenland Mines Ltd (NASDAQ:GRML)
Block, Inc. (NYSE:XYZ)
Netcapital Inc. (NASDAQ:NCPL)
Shopify, Inc. Class A (TSX:SHOP)
Business
WDB coco Co., Ltd. WDB coco Co., Ltd. (7079:TYO) provides contract research organization services primarily focused on safety information management, post-marketing surveillance, and clinical research support for the development of pharmaceuticals and medical devices in Japan. The company offers pharmacovigilance services including safety information management support; post-marketing surveillance operations such as contract conclusion with medical facilities, survey explanations, receipt of survey forms, monitoring, re-surveys, case registration, data management, and statistical analysis; clinical research support and monitoring; support for clinical trials, regulatory affairs, and quality assurance including dossier preparation for product registration, translation, and QC; medical devices development assistance; and temporary staffing or manpower dispatch services. Incorporated in 1984 and headquartered in Tokyo, Japan, at Triton Square Y 27F, 1-8-11 Harumi, Chuo-ku, WDB coco operates four branches domestically and leverages proprietary IT systems and know-how to deliver high-quality, low-cost one-stop solutions for post-marketing and clinical processes, targeting pharmaceutical companies and related sectors. As a subsidiary within the WDB Holdings Co., Ltd. group, it collaborates with affiliates like Cobridge Co., Ltd. for regulatory consulting and Oy Medfiles Ltd. for European and US market support in clinical trials and pharmacovigilance. Recent activities emphasize expansion through group synergies for global operations with hubs in Japan and Finland, alongside standardization and automation of operations to enhance efficiency, though no major acquisitions, funding rounds, or new product launches are reported in the past 1-2 years.